Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer of the PROSTATE”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnded earlyNCT00981578
What this trial is testing

ExAblate Conformal Bone System Treatment of Metastatic Bone Tumors for the Palliation of Pain

Who this might be right for
Bone Metastases
InSightec 37
Not applicableUnknownNCT03709485
What this trial is testing

Evaluation of Gut Microbiome in Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Ziv Hospital 150
Testing effectiveness (Phase 2)Study completedNCT00020735
What this trial is testing

Toremifene Followed by Radical Prostatectomy in Treating Patients With Stage I or Stage II Prostate Cancer

Who this might be right for
Prostate Cancer
Joel Nelson, MD 45
Testing effectiveness (Phase 2)Study completedNCT03565835
What this trial is testing

Abiraterone With Discontinuation of Gonadotropin-Releasing Hormone Analogues in Metastatic Prostate Cancer

Who this might be right for
Prostatic Neoplasms
Montefiore Medical Center 31
Not applicableStudy completedNCT04330716
What this trial is testing

Genetic Testing for Breast, Ovarian, Pancreatic, and Prostate Cancers

Who this might be right for
Breast CancerOvarian CancerPancreatic Cancer+1 more
Dana-Farber Cancer Institute 269
Testing effectiveness (Phase 2)Looking for participantsNCT07223385
What this trial is testing

High Cardiovascular Risk Intervention With Cardio-Oncology Consultation for Prostate Cancer Following Androgen Receptor Pathway Inhibitor (ARPI) Therapy (Heart-Safe)

Who this might be right for
Prostate Cancer (Diagnosis)Prostate Cancer Stage IVCV Risk
Cedars-Sinai Medical Center 80
Testing effectiveness (Phase 2)UnknownNCT03141671
What this trial is testing

Randomized Phase II Study of Salvage XRT + ADT +/- Abiraterone and Apalutamide for Rising PSA After RP (FORMULA-509)

Who this might be right for
Prostate Cancer
Dana-Farber Cancer Institute 345
Testing effectiveness (Phase 2)Ended earlyNCT00006371
What this trial is testing

A Phase II Trial of Early Medical Adrenalectomy for "D0.5" Prostate Cancer

Who this might be right for
Prostate Cancer
H. Lee Moffitt Cancer Center and Research Institute 2
Not applicableUnknownNCT04983706
What this trial is testing

Optimization of the Core Number and Location for Targeted Prostate Biopsy

Who this might be right for
Prostate Cancer
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 100
Early research (Phase 1)Ended earlyNCT04249947
What this trial is testing

P-PSMA-101 CAR-T Cells in the Treatment of Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC) and Advanced Salivary Gland Cancers (SGC)

Who this might be right for
Prostatic Neoplasms, Castration-ResistantNeoplasms by Histologic TypeNeoplasms, Prostate+14 more
Poseida Therapeutics, Inc. 40
Post-approval studies (Phase 4)Study completedNCT02405858
What this trial is testing

Abiraterone Acetate in Metastatic Castration-Resistant Prostate Cancer Participants Who Responded Poorly to the First-line Combined Androgen Blockade Therapy

Who this might be right for
Metastatic Castration-Resistant Prostate Cancer
Janssen Pharmaceutical K.K. 51
Not applicableLooking for participantsNCT06835426
What this trial is testing

High-resolution PET-CT Specimen Imaging for the Perioperative Visualization of Resection Margins

Who this might be right for
Breast CarcinomaProstate Cancer SurgeryThyroid Cancer+10 more
Algemeen Ziekenhuis Maria Middelares 150
Testing effectiveness (Phase 2)Study completedNCT01956058
What this trial is testing

Brachytherapy for Recurrent Prostate Cancer

Who this might be right for
Recurrent Prostate CancerBrachytherapy Remedial
Centre Georges Francois Leclerc 30
Testing effectiveness (Phase 2)Study completedNCT00715078
What this trial is testing

To Evaluate Sipuleucel-T Manufactured With Different Concentrations of (PA2024) Antigen

Who this might be right for
Prostate Cancer
Dendreon 122
Large-scale testing (Phase 3)Study completedNCT02234115
What this trial is testing

Safety, Efficacy, and Pharmacokinetic Behavior of Leuprolide Mesylate in Subjects With Advanced Prostate Carcinoma

Who this might be right for
Prostatic Neoplasms
Foresee Pharmaceuticals Co., Ltd. 137
Not applicableActive Not RecruitingNCT01653093
What this trial is testing

3-Tesla MRI in Finding Tumors in Patients With Known or Suspected Prostate Cancer

Who this might be right for
Prostate Cancer
University of Cincinnati 280
Not applicableLooking for participantsNCT06966778
What this trial is testing

Oxybutynin ER to Promote Early Continence Recovery After Robotic Prostatectomy: A Randomized Controlled Trial

Who this might be right for
Localized Prostate CancerPostoperative Urinary Incontinence
National Taiwan University Hospital 135
Not applicableEnded earlyNCT02177526
What this trial is testing

Imaging of High Grade Prostate Cancer

Who this might be right for
Prostatic Carcinoma
Ottawa Hospital Research Institute 30
Not applicableAvailableNCT06872489
What this trial is testing

Expanded Access Protocol for the Use of SL-28 in the Treatment of Advanced Solid Tumors

Who this might be right for
Neuroblastoma in ChildrenNeuroblastoma, Recurrent, RefractoryAdvanced Cancer+7 more
Second Life Therapeutics
Testing effectiveness (Phase 2)Study completedNCT01059643
What this trial is testing

A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Ovarian CancerNon Small Cell Lung CancerProstate Cancer+4 more
Eli Lilly and Company 103
Next Page